Covalent binding of leukotriene A4 to DNA and RNA

被引:22
|
作者
Hankin, JA
Jones, DNM
Murphy, RC
机构
[1] Natl Jewish Med & Res Ctr, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA
关键词
D O I
10.1021/tx034018+
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Leukotriene A(4) (LTA(4)) is a highly reactive electrophilic intermediate formed during the biosynthesis of the lipid mediators leukotriene B-4 and leukotriene C-4. Deoxynucleosides were found to react as nucleophiles with LTA(4) in aqueous solutions as assessed by UV spectroscopy and electrospray ionization mass spectrometry. Aqueous solutions of native DNA and RNA were also found to react with LTA(4) as assessed by mass spectrometric analysis of the constituent nucleosides derived from enzymatic hydrolysis of the nucleic acids. The most abundant adducts were observed for guanine- and adenine-containing deoxynucleosides and nucleosides. At neutral pH, these reactions led to an overall modification of deoxyguanosine/guanosine residues in DNA and RNA at 15 +/- 1 adducts/10(7) bases and 230 +/- 20 adducts/10(7) bases, respectively, determined by quantitative assay using stable isotope-labeled LTA(4)-nucleoside adduct. An estimation of the relative reactivity of LTA(4) with each of the purine and pyrimidine bases in DNA and RNA was carried out by comparisons of the mass spectral ion abundance of the different adducts (LTA(4)-dAdo, LTA(4)-dCyd, LTA(4)-Thd, LTA(4)-Ado, LTA(4)-Cyd, and LTA(4)-Urd) to the ion signal of known amounts of LTA(4)-dGuo and LTA(4)-Guo standards. The data were corrected for different mass spectrometric response factors that were experimentally determined for each adduct product. The structures of the two most abundant LTA(4)-Guo products were determined by NMR, UV spectroscopy, and mass spectrometry to be 5-hydroxy,12-[Guo-N-2-yl]-6,8,11,14-eicosatetraenoic acid. Stimulation of human neutrophils with calcium ionophore led to the covalent modification of DNA within the cell as determined by mass spectrometric analysis of lipophilic nucleosides obtained after hydrolysis of extracted DNA. These observations, combined with the intracellular site of 5-lipoxygenase translocation and LTA(4) biosynthesis at the nuclear envelope, suggest that LTA(4) may have access to DNA and RNA within cells and furthermore modify nucleic acids in situ following the activation of 5-lipoxygenase and initiation of LTA(4) biosynthesis.
引用
收藏
页码:551 / 561
页数:11
相关论文
共 50 条
  • [1] Covalent binding of leukotriene A4 to nucleosides, nucleotides, and nucleic acids
    Hankin, JA
    Murphy, RC
    ADVANCES IN PROSTAGLANDIN, LEUKOTRIENE, AND OTHER BIOACTIVE LIPID RESEARCH: BASIC SCIENCE AND CLINICAL APPLICATIONS, 2003, 525 : 29 - 33
  • [2] In Silico Modeling of the Molecular Structure and Binding of Leukotriene A4 into Leukotriene A4 Hydrolase
    Paz, Paula B.
    Vega-Hissi, Esteban G.
    Estrada, Mario R.
    Garro Martinez, Juan C.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (06) : 902 - 908
  • [3] Structural characterization of the covalent attachment of leukotriene A3 to leukotriene A4 hydrolase
    Mancini, JA
    Waugh, RJ
    Thompson, JA
    Evans, JF
    Belley, M
    Zamboni, R
    Murphy, RC
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 354 (01) : 117 - 124
  • [4] Leukotriene A4 hydrolase
    Haeggström, JZ
    Kull, F
    Rudberg, PC
    Tholander, F
    Thunnissen, MMGM
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 68-9 : 495 - 510
  • [5] Asn362 Contributes to Zinc Binding by Leukotriene A4 Hydrolase
    Thompson, Michael W.
    Schaible, Alexis
    Seipelt, Rebecca L.
    FASEB JOURNAL, 2010, 24
  • [6] Theoretical Characterization of the Step-by-Step Mechanism of Conversion of Leukotriene A4 to Leukotriene B4 Catalysed by the Enzyme Leukotriene A4 Hydrolase
    Canyelles-Nino, Miquel
    Gonzalez-Lafont, Angels
    Lluch, Jose M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [7] Azabenzthiazole inhibitors of leukotriene A4 hydrolase
    Tanis, Virginia M.
    Bacani, Genesis M.
    Blevitt, Jonathan M.
    Chrovian, Christa C.
    Crawford, Shelby
    De Leon, Aimee
    Fourie, Anne M.
    Gomez, Laurent
    Grice, Cheryl A.
    Herman, Krystal
    Kearney, Aaron M.
    Landry-Bayle, Adrienne M.
    Lee-Dutra, Alice
    Nelson, Jay
    Riley, Jason P.
    Santillan, Alejandro, Jr.
    Wiener, John J. M.
    Xue, Xiaohua
    Young, Arlene L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) : 7504 - 7511
  • [8] Azabenzthiazole inhibitors of leukotriene A4 hydrolase
    Tanis, Virginia M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [9] Novel leukotriene A4 hydrolase inhibitors
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (01) : 91 - 95
  • [10] Benzthiazoles as leukotriene A4 hydrolase inhibitors
    Bacani, Genesis M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243